RHYTHM PHARMACEUTICALS INC (RYTM)

US76243J1051 - Common Stock

39.17  -0.43 (-1.09%)

After market: 39.17 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
91.92M77.43M23.64M3.15M0.00
Cost Of Goods
10.69M9.30M2.13M600.00KN/A
Gross Profit
81.24M68.13M21.51M2.56MN/A
Operating Expenses
352.95M252.48M200.67M172.61M136.58M
Research and Development
225.67M134.95M108.63M104.13M90.45M
Selling, General, and Administrative Expenses
127.29M117.53M92.03M68.49M46.13M
Operating Income
-271.70M-184.36M-179.16M-170.06M-136.58M
Interest Income/Expense
-2.20M53.00K-1.17M450.00K2.58M
Other Income/Expense
903.00K190.00K-790.00K100.00MN/A
Income Before Taxes
-273.01M-184.11M-181.12M-69.61M-134.00M
Income Tax
N/A564.00KN/A0.00N/A
Net Income
-273.87M-184.68M-181.12M-69.61M-134.00M
EBITDA
-270.00M-182.60M-177.49M-168.90M-135.89M
 
Per Share Data
EPS Diluted Total Ops
-4.63-3.20-3.47-1.40-3.04
Non GAAP EPS
-4.63-3.20-3.48-3.41-3.05
 
Statistics
Gross Profit Margin
88.38%87.99%90.99%81.27%N/A
Profit Margin
-297.94%-238.52%-766.16%-2209.84%N/A
Operating Profit Margin
-295.58%-238.10%-757.87%-5398.73%N/A

All data in USD

Charts